Clark et al., 1987 - Google Patents
Activation of human B cell proliferation through surface Bp35 (CD20) polypeptides or immunoglobulin receptors.Clark et al., 1987
- Document ID
- 13551286931552815462
- Author
- Clark E
- Shu G
- Publication year
- Publication venue
- Journal of immunology (Baltimore, Md.: 1950)
External Links
Snippet
Human B cells can be activated with monoclonal antibodies (mAb) to surface IgM receptors or mAb to a 35-kilodalton B cell differentiation antigen, Bp35 (CD20). We compared anti-Ig- induced B cell activation with B cell triggering by anti-Bp35. Both anti-Ig-and anti-Bp35 …
- 102100000165 MS4A1 0 title abstract description 45
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Clark et al. | Activation of human B cell proliferation through surface Bp35 (CD20) polypeptides or immunoglobulin receptors. | |
Hara et al. | Human T cell activation. I. Monocyte-independent activation and proliferation induced by anti-T3 monoclonal antibodies in the presence of tumor promoter 12-o-tetradecanoyl phorbol-13 acetate. | |
Tedder et al. | The B cell surface molecule B1 is functionally linked with B cell activation and differentiation. | |
Clark et al. | Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. | |
Pezzutto et al. | CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. | |
Yang et al. | A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants. | |
Hurwitz et al. | Characterization of a leukemic cell line of the pre‐B phenotype | |
Fleischer | A novel pathway of human T cell activation via a 103 kD T cell activation antigen. | |
Ledbetter et al. | Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression. | |
Clarkson et al. | CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes. | |
Ledbetter et al. | Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). | |
Ledbetter et al. | Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells. | |
US5182368A (en) | Ligands and methods for augmenting B-cell proliferation | |
Kozbor et al. | Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells. | |
Groux et al. | A 19-kDa human erythrocyte molecule H19 is involved in rosettes, present on nucleated cells, and required for T cell activation. Comparison of the roles of H19 and LFA-3 molecules in T cell activation. | |
Anasetti et al. | Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16). | |
US5786456A (en) | Bp 50-specific antibodies and fragments thereof | |
Spertini et al. | Induction of human T cell proliferation by a monoclonal antibody to CD5. | |
Welte et al. | OKT8 antibody inhibits OKT3-induced IL 2 production and proliferation in OKT8+ cells. | |
Greenberg et al. | Characteristics of the effector cells mediating cytotoxicity against antibody‐coated target cells. II. The mouse nonadherent K cell | |
Okudaira et al. | Anti-Ia reactivity in sera from patients with systemic lupus erythematosus | |
Daish et al. | Expression of the CMRF-35 antigen, a new member of the immunoglobulin gene superfamily, is differentially regulated on leucocytes. | |
Bekoff et al. | Activation requirements for normal T cells: accessory cell-dependent and-independent stimulation by anti-receptor antibodies. | |
Vander-Mallie et al. | Lymphocytes bearing Fc receptor for IgE. VIII. Affinity of mouse IgE for Fc epsilon R on Mouse B lymphocytes. | |
WO1995012409A1 (en) | Dendritic cell-specific antibodies and methods for their preparation |